Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

27.04.15	ACT Gets Its Act Right, AKRX Shrivels, CUPID2 Misses Targets, GWPH On A High (RTTNews)
24.04.15	Eli Lilly: FDA Grants Fourth Approval For Cyramza (RTTNews)
23.04.15	Eli Lilly Q1 Profit Falls On Patent Expiries, Currency Impact (RTTNews)
23.04.15	Pre-market Movers For April 23 (GM, FB, PEP, PG, DB, CAT, DOW, LLY, EBAY, ERIC) (RTTNews)
23.04.15	Eli Lilly Q1 Profit Down; Cuts FY15 EPS View - Quick Facts (RTTNews)
20.04.15	Eli Lilly: Ixekizumab Meets Primary Endpoint In Psoriatic Arthritis Study (RTTNews)
17.04.15	Bristol-Myers Transfers Erbitux Rights In North America To Lilly (RTTNews)
02.04.15	OncoMed And Lilly To Evaluate Combination Of Demcizumab,Alimta In Lung Cancer (RTTNews)
31.03.15	Indianapolis Star On 'Anti-Gay' Law: Fix This Now (RTTNews)
26.03.15	EBS, REGN Get FDA Nod, OVAS To Deliver, Recro Recuperates, Watch Out For ZSAN (RTTNews)
23.03.15	Eli Lilly & Boehringer Announce Availability Of Glyxambi Tablets In U.S. (RTTNews)
23.03.15	Pfizer & Eli Lilly To Resume Tanezumab Phase 3 Program - Quick Facts (RTTNews)
20.03.15	Eli Lilly & Innovent Biologics Announce Collaboration - Quick Facts (RTTNews)
19.03.15	Eli Lilly & Hanmi Collaborate To Develop Hanmi's Tyrosine Kinase Inhibitor (RTTNews)
06.03.15	German Appeal Court Says Generic Product Would Not Infringe Eli Lilly's Alimta (RTTNews)
03.03.15	Denovo Biopharma Licenses Pomaglumetad From Eli Lilly - Quick Facts (RTTNews)
24.02.15	BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back (RTTNews)
23.02.15	Lilly Delays Regulatory Submission On Basal Insulin Peglispro - Quick Facts (RTTNews)
23.02.15	Lilly: Baricitinib Superior To Placebo In Reducing Rheumatoid Arthritis Activity (RTTNews)
20.02.15	Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going (RTTNews)
19.02.15	Eli Lilly Extends Phase 3 Trial Of Evacetrapib By Approx. Six Months (RTTNews)
02.02.15	Lilly : FDA OKs First-in-class Glyxambi Tablets For Adults With Type 2 Diabetes (RTTNews)
30.01.15	Eli Lilly Q4 Adj. Profit Beats View, Lowers 2015 Revenue Guidance (RTTNews)
30.01.15	Eli Lilly Q4 Profit Tops Estimates - Quick Facts (RTTNews)
14.01.15	LLY Collaborates With BMY And MRK, CLTX On Watchlist, ZLTQ Continues To Grow (RTTNews)
13.01.15	Bristol-Myers, Lilly To Evaluate Opdivo In Combination With Galunisertib (RTTNews)
13.01.15	Merck, Eli Lilly In Oncology Clinical Trial Collaboration - Quick Facts (RTTNews)
01.01.15	Novartis Closes Sale Of Animal Health Business To Eli Lilly For $5.4 Billion (RTTNews)
19.12.14	Eli Lilly, Adocia Team Up On Developing Ultra-rapid Insulin BioChaperone Lispro (RTTNews)
16.12.14	FDA Okays Lilly's CYRAMZA To Treat Non-Small Cell Lung Cancer (RTTNews)
13.12.14	Lilly's Oncology Drug Cyramza Scores FDA Approval For Another Indication (RTTNews)
09.12.14	Eli Lilly, Incyte Say Arthritis Drug Baricitinib Meets Primary Endpoint (RTTNews)
08.12.14	Anthem, Eli Lilly, HealthCore Form Research Collaboration - Quick Facts (RTTNews)
02.12.14	Zosano & Eli Lilly To Develop ZP-PTH For Treatment Of Osteoporosis Patients (RTTNews)
01.12.14	Eli Lilly, AstraZeneca Enroll First Patient Into AMARANTH - Quick Facts (RTTNews)
10.11.14	Lilly Announces U.S. Availability Of Trulicity (RTTNews)
05.11.14	FDA Oks Cyramza Combined With Paclitaxel For Gastric Cancer Prior Chemotherapy (RTTNews)
29.10.14	Lilly, Boehringer Ingelheim Revise Diabetes Alliance In Certain Countries (RTTNews)
28.10.14	Judge Slashes Penalty In Case Against Eli Lilly, Takeda On Diabetes Drug Actos (RTTNews)
27.10.14	Virbac To Buy Veterinary Assets From Eli Lilly In U.S. - Quick Facts (RTTNews)
23.10.14	Lilly Q3 Profit Falls 58% (RTTNews)
23.10.14	Lilly Q3 Non-GAAP EPS Misses View; Revises Reported EPS View - Quick Facts (RTTNews)
21.10.14	FDA Accepts Lilly's NDA Filing For Empagliflozin/metformin Combination (RTTNews)
16.10.14	Lilly To Realign Puerto Rico Manufacturing Operations - Quick Facts (RTTNews)
08.10.14	Novartis Unveils Executive Committee Changes Post Portfolio Transactions (RTTNews)
03.10.14	EU Approves Eli Lilly's Acquisition Of Novartis Animal Health Business (RTTNews)
03.10.14	EU Okays Acquisition Of Novartis Animal Health Business By Lilly (RTTNews)
02.10.14	Lilly To Record Charge In Q3 As It Discontinue Development Of Tabalumab (RTTNews)
19.09.14	Lilly Says FDA Approves Type 2 Diabetes Drug Trulicity (RTTNews)
18.09.14	Lilly's Phase III Trial Of Cyramza With Paclitaxel Meets Endpoints (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus